PharmiWeb.com - Global Pharma News & Resources

Recruitment - Articles

As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences.
As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences. In such an ever changing environment it is difficult to keep on top of what ‘best practice’ actually is, and how new technologies can enable more engaging conversations with stakeholders.The webcast has now become a standard part of the toolkit for communications teams to create connections between Key Opinion Leaders (KOLs), stakeholders and journalists. However with the c…
Many employers will agree with David Cameron, that a decade of Health and Safety rules and regulations intended to protect people, have in fact simply overwhelmed businesses with extra red tape.
Many employers will agree with David Cameron, that a decade of Health and Safety rules and regulations intended to protect people, have in fact simply overwhelmed businesses with extra red tape. Whilst the Government have announced a review of the current rules, which we hope will bring an end to extreme examples of health and safety gone mad, such as the tragic case of the ten year old boy allowed to drown by community police officers who were not “trained” to go into the water or schools banning children from playing conkers in the school yard, employers will still need to understand and be awa…
It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.
It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.Traditionally, employers have expected an employee’s doctor to assess their capability to work. However, an independent review into sickness absence…
ABBYY and partner Document Genetics team up to streamline critical business processes
ABBYY and partner Document Genetics team up to streamline critical business processesBackgroundIn the face of the growing assortment of pharmaceutical products, PharmacoVigilance, or the pharmacological science of detecting and assessing the side effects of medicines, has become an important issue to both drug companies and consumers alike. In order to identify new information about the hazards associated with medicines and to prevent harm to patients, data from healthcare providers and individuals need to be collected, monitored, researched, assessed and evaluated. The PV evaluation process, however, involves significant amounts of time, particularly to process the large volume of documents.Because of the…
We’re seeing increasing demand for pharma marketing solutions to be based on the iPad, and it’s not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to be increasing. But what’s interesting is that remote ‘self-service’ edetailing does not seem to be growing at the same rate. The predicted disintermediation of the traditional field sales model hasn’t happened.
We’re seeing increasing demand for pharma marketing solutions to be based on the iPad, and it’s not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to  be increasing. But what’s interesting is that remote ‘self-service’ edetailing does not seem to be growing at the same rate. The predicted disintermediation of th…
How common is it to work during your vacation? - Take our short survey.
How common is it to work during your vacation? We're doing some research to find out more about current trends, and the amount of work people undertake on their vacation, as well as how they do it. So, if you could help us by completing our short survey, I will put your name into the hat for some PharmiWeb.com freebies. (I've got mugs, pens, mouse mats, and all sorts of goodies) Thanks for your help!- The results will be published in due course. >>>CLICK HERE TO TAKE PART IN THE SURVEY<<<
For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary.
For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary. Interviewing is a skill in and of itself, and there are a number of commonalities when it comes to making sure that one’s interview is succ…
Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the shape of the state has already changed.
Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the sha…
Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC trial presented at the European League Against Rheumatism (EULAR) meeting in London, May 25-28 (abstract FRI021).
Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC tri…
Want to know which Pharma companies are on Twitter? - here's a list..
I've been keeping track on the pharma companies on Twitter, and the presence and activity varies significantly. Anyway here is the current list for your reference. If you notice any errors or omissions, let me know.  ABPIAccess pharmaActavisAkzonobelAllerganAlnylamAmgenAmgen FoundationAstellas USAstra Zeneca JobsAstraZenecaAstraZeneca - joinastrazenecaAstrazeneca USAstraZenecaNLAzco BiotechAZhelpsBaxterBayerBayer HealthCareBayer JovensBayer PressBayer SanteBayer ScheringBayer SDBayer UK / IrelandBayer US NewsBayer US NewsBayer VitalBayerM SMSBioIndustry AssociationBMS NewsbmsinfoBoehringerBoehringer GermanyBoehringer GreeceBoehringer SpainBoehringer USBoehringernldBristol_MyersDaiichi SankyoDiabetes_sanofiElan…
Since the very dawn of Western capitalism, competition has been synonymous with success. Indeed, in accounting for the past 500 years of Western ascendancy in the world, Professor Niall Ferguson of Harvard University points to six ‘killer apps’. The first of these, unsurprisingly, is competition
Since the very dawn of Western capitalism, competition has been synonymous with success. Indeed, in accounting for the past 500 years of Western ascendancy in the world, Professor Niall Ferguson of Harvard University points to six ‘killer apps’. The first of these, unsurprisingly, is competition. However in the world of healthcare, this theory has faced more than its fair share of criticism. Doubtless, few sensible men would argue that healthcare has not benefitted from the entrepreneurial pressur…
Earlier this month the UK drugs giant GlaxoSmithKline announced a groundbreaking and progressive new scheme for graduates, whereby from 2012 the company will offer to reimburse in full the university tuition fees of the entirety its future graduate intake.
In the final months of 2010, the subject of student tuition fees dominated our political discourse. What originated as relatively civil and contained acts of protest quickly mutated into angry and ultimately violent conflict at the heart of Britain’s capital city. The bellowing voice of extremism had once again drowned out the silent minority and images of discord and chaos dominated our television screens. At the zenith of the violence, the London headquarters of the Conservative Party was attacked, destroying the building’s main lobby…
After six months of sometimes lively pursuit, the French pharmaceutical group, Sanofi-aventis, has agreed a deal to pay $20.1bn in cash for U.S. biotech firm Genzyme Corp after Sanofi made an increased offer of $74 per share.
Once completed, the deal will represent the biggest pharmaceutical takeover since 2009 and the largest acquisition by the group since its $50bn purchase of Aventis back in 2004. In view of excited predictions from Genzyme executives on potential sales of Lemtrada (alemtuzumab), each share will also be linked to tradable Contingent Value Rights (CVRs) worth up to $14 a share if all performance milestones are reached. While Genzyme predicts sales for Lemtrada approaching $3.5bn, Sanofi has been somewhat more reserved in its estimates. While payments mainly depend on th…
Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site.
Out there on the branding battlefields its simply do or die as brand images are either hyper visible or mortally lost in oblivion. Commanding success for any idea on the global scene demands universal access on e-commerce that is only deliverable by a cyber name identity, as it's the only key to open the site. Without it, accessibility to any cyber empire is simply doomed, dragging expansion dreams into cyber oblivion. Millions of million-dollar websites have slipped into the abyss,…
The Kingdom of Saudi Arabia provides a new opportunity for clinical research, and can open doors to untapped populations, explains Rani Abraham at ClinTec International
Recently, there has been a definite increase in the potential for investment in the clinical trials sector in the Kingdom of Saudi Arabia (KSA). Certain reforms in the sector such as the establishment of the Saudi Food and Drug Authority (SFDA)and the growth of the local pharmaceutical and healthcare industries, in combination with the growing importance of data from different races or ethnic populations, have made KSA an attractive country for conducting clinical trials. In the last decade, ethnicity and socio-economic differences in relation to disease incidence, diagnosis and prognosis have attracted attention. The inclus…
There has been some conjecture amongst professionals regarding the merits of a personal profile on a CV. This conjecture stems from the fact that many job seekers fill there personal profiles with irrelevant and mostly clichéd information.
There has been some conjecture amongst professionals regarding the merits of a personal profile on a CV. This conjecture stems from the fact that many job seekers fill there personal profiles with irrelevant and mostly clichéd information. Here at the CV & Interview Advisors, we offer free CV Appraisals, therefore see hundreds of CVs per week. I recently reviewed 5 CVs back-to-back and was interested to find that all 5 people considered themselves to be dynamic and innovative with excellent communication skills. Having spoken to all 5 individuals, it…
In my capacity as a Career Consultant, I have worked closely with freelancers & contractors for many years and two challenges keep rearing their ugly head: Firstly, how does a freelancer write a CV that isn’t six pages long; and secondly, what happens if you want to apply for a role that draws upon skills gained in a contract that isn’t the most recent piece of work that you have done.
In my capacity as a Career Consultant, I have worked closely with freelancers & contractors for many years and two challenges keep rearing their ugly head: Firstly, how does a freelancer write a CV that isn’t six pages long; and secondly, what happens if you want to apply for a role that draws upon skills gained in a contract that isn’t the most recent piece of work that you have done. I anticipate lots o…
The role of a seasoned pharmacist has some obvious kind of benefits attached with it. This basically includes the role that they play and the kind of work carried out by them including learning the trade from a well-known lead pharmacist.
The role of a seasoned pharmacist has some obvious kind of benefits attached with it. This basically includes the role that they play and the kind of work carried out by them including learning the trade from a well-known lead pharmacist. The first step in this career is that of a technician that grows further until one becomes a lead pharmacist in a reputed organization. Since these pharmacist start out as complete strangers offering medicines to the patients prescribed by the doctor or physician their role becomes extremely crucial within the healthcare…
27-Aug-2010
We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley.
We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley. Indeed, not only is our health service inefficient, but it is incredibly disconnected from the people it’s meant to serve - the patients. For these reasons and others, Mr. Lansley is proposing the biggest shake-up of the health service in 60 years. 'Our guiding principle', Mr. Lansley says, will be ‘no decision about me, witho…
During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare.
During a time of major economic downturn, there are few industries that can be said to be truly ‘recession proof’. Yet for years now, big pharma has largely been seen as precisely that. After all, no matter dire the markets, and no matter how low consumer confidence plummets, there is always a demand for healthcare. Seen from this angle then, it’s almost as good as mandatory spending. Yet as the most recent global economic slowdown has shown, healthcare and big pharma aren’t qu…